Skip to main content

Calamos Advisors LLC

SEC CIK
0001316507
Latest filing
Jul 31, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Calamos Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
399,893
Value
$100.6M
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Calamos Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026399,893$100.6M0.4%−83,777−17.3%ReducedHolders
Q1 2026483,670$105.2M0.4%+17,380+3.7%AddedHolders
Q4 2025466,290$106.5M0.4%+15,458+3.4%AddedHolders
Q3 2025450,832$104.4M0.4%−19,186−4.1%ReducedHolders
Q2 2025470,018$87.2M0.4%−31,743−6.3%ReducedHolders
Q1 2025501,761$105.1M0.5%+58,470+13.2%AddedHolders
Q4 2024443,291$78.8M0.4%+517+0.1%AddedHolders
Q3 2024442,774$87.4M0.4%−6,730−1.5%ReducedHolders
Q2 2024449,504$77.1M0.4%−11,105−2.4%ReducedHolders
Q1 2024460,609$83.9M0.4%−7,859−1.7%ReducedHolders
Q4 2023468,468$72.6M0.4%−3,918−0.8%ReducedHolders
Q3 2023472,386$70.4M0.4%+578+0.1%AddedHolders
Q2 2023471,808$63.6M0.3%−1940.0%ReducedHolders
Q1 2023472,002$75.2M0.4%−43,633−8.5%ReducedHolders
Q4 2022515,635$83.3M0.4%−69,387−11.9%ReducedHolders
Q3 2022585,022$78.5M0.4%−60,958−9.4%ReducedHolders
Q2 2022645,980$98.9M0.4%+12,694+2.0%AddedHolders
Q1 2022633,286$102.7M0.4%+86,633+15.8%AddedHolders
Q4 2021546,653$74.0M0.3%+15,202+2.9%AddedHolders
Q3 2021531,451$57.3M0.3%+62,014+13.2%AddedHolders
Q2 2021469,437$52.9M0.3%+203,536+76.5%AddedHolders
Q1 2021265,901$28.8M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.